	Label	Description
	G01650EU Compound (Entity type)	type="Composition" mass="1890.66104015" permass="2367.19314253" monosaccharides="10" is_motif="False...
	G46503DX Compound (Entity type)	type="Composition" mass="1898.67735889" permass="2361.1938112" monosaccharides="9" is_motif="False" ...
	G28541PG Compound (Entity type)	type="BaseComposition" mass="1599.56562351" permass="2006.01947554" monosaccharides="9" is_motif="Fa...
	p26012-1 402asn 402asn defined go:0006486 go:0006487 Post Translational Modification (Entity type)	A Post Translational Modification
	ITB8 HUMAN Protein (Entity type)	Integrin beta-8 (precursor)

G01650EU

type="Composition" mass="1890.66104015" permass="2367.19314253" monosaccharides="10" is_motif="False...

G46503DX

type="Composition" mass="1898.67735889" permass="2361.1938112" monosaccharides="9" is_motif="False" ...

G28541PG

type="BaseComposition" mass="1599.56562351" permass="2006.01947554" monosaccharides="9" is_motif="Fa...

p26012-1 402asn 402asn defined go:0006486 go:0006487

A Post Translational Modification

ITB8 HUMAN

Integrin beta-8 (precursor)

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.